Wednesday, June 10, 2026

pharma Β· Inflammatory Bowel Disease (IBD) Β· Melanoma Β· IRON

Disc Medicine

Disc Medicine clinical programs β€” 308 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US HQ
165 Employees
Public company Type
IRON Β· NYSE Ticker
Company details
Status
Public
HQ
321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
Employees
165
Programs
308
Drugs
442
Patents
706
Intelligence Β· Clinical Programs

Disc Medicine projects

308 ClinicalTrials.gov programs sponsored by Disc Medicine.

Disc Medicine has 308 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

Page 7 of 7
  1. Sodium Chloride 0.9% for Vulvar High-Grade Squamous Intr…

    Disc Medicine

    Vulvar High-Grade Squamous Intraepithelial Lesion (vHSIL)

    approved small molecule active

    1 trial
  2. Sodium Chloride Fresenius Kabi Italia 0 for Systemic sclerosis

    Disc Medicine

    Systemic sclerosis

    approved small molecule active

    1 trial
  3. Sodium Chloride Fresenius Kabi Italia 0.9 % S...

    Disc Medicine

    Fibrous dysplasia/McCune-Albright syndrome

    approved small molecule active

    1 trial
  4. Sovaldi 400 mg film-coated tablets

    Disc Medicine

    Healthy volunteers

    approved small molecule active

    1 trial
  5. Sugammadex hameln /ml oplossing voor injectie for General anesthesia

    Disc Medicine

    General anesthesia

    approved small molecule active

    1 trial
  6. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial
  7. TAGRISSO 80 mg film-coated tablets

    Disc Medicine

    EGFR mutated locally advanced or metastatic non-small cell lung cancer

    approved small molecule active

    1 trial
  8. TAMOXIFEN

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial
  9. TICAGRELOR

    Disc Medicine

    Acute coronary syndrome

    approved small molecule active

    1 trial
  10. Talzenna 1 mg hard capsules

    Disc Medicine

    Breast cancer

    approved small molecule active

    1 trial
  11. Tetanusvaccin, suspensie voor injectie 40 IE

    Disc Medicine

    Systemic sclerosis, Systemic lupus erythematosus, Rheumatoid arthritis

    approved small molecule active

    1 trial
  12. Ultomiris 300 mg/30 mL concentrate for solution for infusion

    Disc Medicine

    Paroxysmal nocturnal hemoglobinuria (PNH)

    approved small molecule active

    1 trial
  13. V0001699

    Disc Medicine

    Oral cancer

    approved small molecule active

    1 trial
  14. VENLAFAXINE

    Disc Medicine

    Major Depressive Disorder

    approved small molecule active

    1 trial
  15. Vaxigrip Tetra for healthy individuals

    Disc Medicine

    healthy individuals

    approved small molecule active

    1 trial
  16. XELJANZ 11 mg prolonged-release tablets

    Disc Medicine

    Rheumatoid arthritis or psoriatic arthritis according to respectively 2010 criteria or CASPAR criteria

    approved small molecule active

    1 trial
  17. [68Ga]FAPI-46

    Disc Medicine

    Non-resolving ARDS

    approved small molecule active

    1 trial
  18. [68Ga]FAPI-46

    Disc Medicine

    post-acute sequelae of COVID-19

    approved small molecule active

    1 trial
  19. [68Ga]FAPI-46

    Disc Medicine

    Peyronie's Disease

    approved small molecule active

    1 trial
  20. Adiposity and Iron Requirements in Pregnancy (ADIPREG)

    Disc Medicine

    Iron Deficiency Anemia of Pregnancy

    other active

    1 trial

Frequently asked questions

How many clinical projects does Disc Medicine have?

308 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.